Spinogenix
9 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate the Effects and Safety of SPG601 for the Treatment of Fragile X Syndrome in Male Participants (NCT07439510) | Spinogenix | 2026-03-01 |
| Efficacy and Safety of Tazbentetol in ALS Participants (NCT07325591) | Spinogenix | 2026-03-01 |
| Extension Study of Participants From SPG302-ALS-001 (NCT06903286) | Spinogenix | 2025-05-29 |
| Extension Study of Participants From SPG302-ALZ-101 (NCT06833281) | Spinogenix | 2025-03-25 |
| Study of SPG302 in Adults With Schizophrenia (NCT06442462) | Spinogenix | 2024-08-01 |
| Study of SPG302 in Adult Participants With Mild-to-Moderate Alzheimer's Disease (AD) (NCT06427668) | Spinogenix | 2024-07-29 |
| Study of SPG601 in Adult Men With Fragile X Syndrome (NCT06413537) | Spinogenix | 2024-07-05 |
| Study of SPG302 in Healthy Volunteers and ALS Participants (NCT05882695) | Spinogenix | 2023-07-03 |
Track Spinogenix automatically
Every clearance here is in the API, with alerts when new ones post.